--- title: "Endovia Health Sciences (EDVA) news: delisting" url: "https://aibio.space/companies/endovia-health-sciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "EDVA delisting and convertible notes news: Splash Beverage Group (now Endovia Health Sciences) faces NYSE American warrant delisting." --- EDVA Endovia Health Sciences, Inc. AMEX · United States # Endovia Health Sciences (EDVA) news EDVA delisting and convertible notes news Financings · 2026-10-27 ## [Endovia Health Sciences raises equity line ceiling to $135 million](https://aibio.space/news/endovia-health-sciences-raises-equity-line-ceiling-135-million/) An addendum with C/M Capital Master Fund lifts the facility's maximum commitment from $35 million to $135 million. The filing does not say how much stock has been sold under it. ## Latest Endovia Health Sciences news 1. 2026-09-18 Debt Financing [Endovia closes $510,000 secured convertible note from C/M Capital](https://aibio.space/news/endovia-closes-510-000-secured-convertible-note-c-m-capital/) C/M Capital Master Fund, LP is the investor. The $510,000 note converts at the lower of $1.75 and $0.01 above the closing price, and the company had $242,702 in cash and cash equivalents at June 30, 2026. 2. 2025-07-29 Listings [Splash Beverage Group (now Endovia Health Sciences) faces NYSE American warrant delisting](https://aibio.space/news/splash-beverage-group-now-endovia-health-sciences-faces-nyse-american/) The exchange suspended trading in the company's $184.00 warrants because of their low trading price. The common stock is not affected. ## Endovia Health Sciences at a glance - **Ticker**: EDVA - **Listing**: AMEX - **Country**: United States - **Cash, Jun 30, 2026**: $242,702 ### Related companies - [Bone Biologics](https://aibio.space/companies/bone-biologics/) NASDAQ: BBLG - [Dyadic International](https://aibio.space/companies/dyadic-international/) NASDAQ: DYAI - [Celularity](https://aibio.space/companies/celularity/) NASDAQ: CELU - [Alpha Cognition](https://aibio.space/companies/alpha-cognition/) NASDAQ: ACOG - [Nutriband](https://aibio.space/companies/nutriband/) NASDAQ: NTRB - [MiMedx Group](https://aibio.space/companies/mimedx/) NASDAQ: MDXG - [Lantheus Holdings](https://aibio.space/companies/lantheus/) NASDAQ: LNTH - [Creative Medical Technology Holdings](https://aibio.space/companies/creative-medical-technology/) NASDAQ: CELZ ### Also on AMEX - [Oragenics](https://aibio.space/companies/oragenics/) OGEN - [Armata Pharmaceuticals](https://aibio.space/companies/armata-pharmaceuticals/) ARMP - [Nasus Pharma](https://aibio.space/companies/nasus-pharma/) NSRX - [Impact BioMedical](https://aibio.space/companies/impact-biomedical/) IBO - [Serina Therapeutics](https://aibio.space/companies/serina-therapeutics/) SER - [Lineage Cell Therapeutics](https://aibio.space/companies/lineage-cell-therapeutics/) LCTX ## Endovia Health Sciences annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$73,066](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | [$801,273](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | | Net income (loss) | [-$25.2 million](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | [-$23.8 million](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | | Cash from operations | [-$4.8 million](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | [-$7.3 million](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | | Cash and equivalents | [$281,435](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001102/) | [$13,789](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000577/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $242,702. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Endovia Health Sciences Was Endovia Health Sciences delisted? Our latest story on this, dated Jul 29, 2025: "Splash Beverage Group (now Endovia Health Sciences) faces NYSE American warrant delisting". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/splash-beverage-group-now-endovia-health-sciences-faces-nyse-american/). Has Endovia Health Sciences sold convertible notes? Our latest story on this, dated Sep 18, 2026: "Endovia closes $510,000 secured convertible note from C/M Capital". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/endovia-closes-510-000-secured-convertible-note-c-m-capital/). What is the ticker symbol of Endovia Health Sciences? Endovia Health Sciences, Inc. trades under the ticker EDVA on AMEX. Where is Endovia Health Sciences listed? Endovia Health Sciences, Inc. is listed on AMEX. What is the SEC CIK of Endovia Health Sciences? The SEC Central Index Key (CIK) for Endovia Health Sciences, Inc. is 1553788. Its filings are on SEC EDGAR. How many shares does Endovia Health Sciences have outstanding? 6,412,521 shares as of 2026-08-19, per the cover page of its 10-Q filed 2026-08-19. Which country or territory is Endovia Health Sciences listed under? Our directory records Endovia Health Sciences, Inc. under United States. What does Endovia Health Sciences do? Our directory classifies Endovia Health Sciences, Inc. as: Biopharma / pharmaceuticals. This is a directory classification, not a description of the pipeline. What is the ISIN of Endovia Health Sciences? The ISIN recorded for Endovia Health Sciences, Inc. is US84862C4015. Does aibio.space cover Endovia Health Sciences? aibio.space lists Endovia Health Sciences, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Endovia Health Sciences incorporated? SEC records list its state or country of incorporation as NV. What was Endovia Health Sciences's revenue last year? $73,066 for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Endovia Health Sciences profitable? Endovia Health Sciences, Inc. reported a net loss of $25.2 million for the fiscal year ended Dec 31, 2025, and used $4.8 million of cash in operations, per its annual report to the SEC. How much cash does Endovia Health Sciences have? $242,702 in cash at Jun 30, 2026, per its 10-Q. What is the latest Endovia Health Sciences (EDVA) stock news? Our latest story on Endovia Health Sciences, dated Oct 27, 2026: "Endovia Health Sciences raises equity line ceiling to $135 million". An addendum with C/M Capital Master Fund lifts the facility's maximum commitment from $35 million to $135 million. The filing does not say how much stock has been sold under it. [Source](https://aibio.space/news/endovia-health-sciences-raises-equity-line-ceiling-135-million/). ## Investor discussion: Endovia Health Sciences Members talk about Endovia Health Sciences (EDVA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Endovia Health Sciences, newest first. Each line links the filing it comes from. 1. 2026-10-27 Financings Reported a financing. SEC Form 8-K (Items 1.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001375/e8027_8k.htm) 2. 2026-10-23 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001369/e8017_pre14a.htm) 3. 2026-08-25 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001144/e7891_ex99-1.htm) 4. 2026-08-21 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001120/e7881_ex99-1.htm) 5. 2026-08-17 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001081/e7859_nt10q.htm) 6. 2026-07-16 Listings Reported a reverse stock split. SEC Form 8-K (Items 5.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000950/e7787_8-k.htm) 7. 2026-07-14 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000936/e7777_ex99-1.htm) 8. 2026-07-09 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000927/e7768_ex99-1.htm) 9. 2026-06-15 Financings Reported a financing. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000853/e7719_ex99-1.htm) 10. 2026-06-03 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000810/e7685_ex99-1.htm) 11. 2026-05-15 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000741/e7649_nt10-q.htm) 12. 2026-05-05 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 1.01,1.02,3.01,3.02,5.03,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/e7604_ex99-1.htm) 13. 2026-04-01 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000516/e7510_nt10-k.htm) 14. 2026-03-12 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 7.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112226000385/e7423_8-k.htm) 15. 2025-12-10 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 1.01,1.02,3.02,5.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001659/e7115_8-k.htm) 16. 2025-11-17 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001558/e7044_nt10-q.htm) 17. 2025-10-06 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001357/e6934_def14a.htm) 18. 2025-09-26 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001308/e6875_pre14a.htm) 19. 2025-09-04 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.03,5.07,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001195/e6819_8-k.htm) 20. 2025-08-14 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001134/e6781_10-q.htm) 21. 2025-08-05 Listings Filed to remove its shares from exchange listing. SEC Form 25-NSE. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000114331325000052/xslF25X02/primary_doc.xml) 22. 2025-07-29 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225001046/e6743_ex99-1.htm) 23. 2025-07-11 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000964/e6689_10-k.htm) 24. 2025-06-13 Listings Reported a reverse stock split. SEC Form 8-K (Items 1.01,3.02,3.03,5.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000876/e6643_8k.htm) 25. 2025-05-16 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000773/e6606_nt10q.htm) 26. 2025-04-17 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000584/e6526_8-k.htm) 27. 2025-04-11 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000569/e6506_ex99-1.htm) 28. 2025-04-03 Listings Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.02,5.03). [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000508/e6482_8-k.htm) 29. 2025-04-01 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112225000492/e6472_nt10-k.htm) 30. 2024-11-15 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1553788/000173112224001819/e6133_nt10q.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open AMEX:EDVA on TradingView](https://www.tradingview.com/symbols/AMEX-EDVA/). ## SEC filings and registration - **SEC name**: Endovia Health Sciences, Inc. - **CIK**: 1553788 - **Industry (SIC)**: Beverages (2080) - **US tickers**: EDVA (NYSE) - **State or country of incorporation**: NV - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 1112 N FLAGLER DRIVE, FORT LAUDERDALE, FL, 33304 - **Phone**: (954) 648-7238 - **Shares outstanding**: 6,412,521 as of 2026-08-19 (10-Q filed 2026-08-19) - **Former names**: SPLASH BEVERAGE GROUP, INC.; Canfield Medical Supply, Inc. ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001347/e8010_8-k.htm) filed 2026-10-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001320/e7994_8k.htm) filed 2026-10-06 - [DEF 14A](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001316/e7987_def14a.htm) filed 2026-10-05 - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001312/e7991_8k.htm) filed 2026-10-05 - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001281/e7970_8k.htm) filed 2026-09-24 - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001271/e7964_8k.htm) filed 2026-09-22 - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001173/e7903_8-k.htm) filed 2026-08-31 - [8-K](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001170/e7901_8-k.htm) filed 2026-08-28 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001553788), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Endovia Health Sciences, Inc. is a public biotech or pharmaceutical company listed on AMEX under the ticker EDVA, recorded under United States. The directory classifies it as Biopharma / pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Endovia Health Sciences, Inc. - **Ticker**: EDVA - **Listing**: AMEX - **Country or territory**: United States - **Business scope**: Biopharma / pharmaceuticals - **ISIN**: US84862C4015 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/AMEX-EDVA/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/endovia-health-sciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Endovia Health Sciences (EDVA) news: delisting", 2026-10-31, https://aibio.space/companies/endovia-health-sciences/